CHARLES SCHWAB INVESTMENT MANAGEMENT INC - NEOGENOMICS INC ownership

NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 341 filers reported holding NEOGENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of NEOGENOMICS INC
ValueSharesWeighting
Q3 2023$12,358,683
-22.2%
1,004,771
+1.7%
0.00%
-20.0%
Q2 2023$15,882,302
-6.2%
988,320
+1.7%
0.01%0.0%
Q1 2023$16,925,585
+87.7%
972,176
-0.4%
0.01%
+66.7%
Q4 2022$9,018,803
+10.7%
976,061
+3.2%
0.00%0.0%
Q3 2022$8,144,000
+7.1%
945,830
+1.3%
0.00%0.0%
Q2 2022$7,607,000
-31.7%
933,247
+1.8%
0.00%0.0%
Q1 2022$11,145,000
-63.6%
917,183
+2.3%
0.00%
-66.7%
Q4 2021$30,593,000
-27.8%
896,587
+2.1%
0.01%
-35.7%
Q3 2021$42,358,000
+10.8%
878,049
+3.7%
0.01%
+7.7%
Q2 2021$38,234,000
-3.5%
846,418
+3.1%
0.01%
-13.3%
Q1 2021$39,606,000
-4.4%
821,190
+6.7%
0.02%
-6.2%
Q4 2020$41,432,000
+43.1%
769,539
-1.9%
0.02%
+23.1%
Q3 2020$28,947,000
+17.9%
784,678
-1.0%
0.01%
+8.3%
Q2 2020$24,559,000
+28.0%
792,705
+14.1%
0.01%
+9.1%
Q1 2020$19,180,000
-3.9%
694,658
+1.8%
0.01%0.0%
Q4 2019$19,965,000
+56.6%
682,537
+2.4%
0.01%
+37.5%
Q3 2019$12,747,000
+2.5%
666,664
+17.6%
0.01%0.0%
Q2 2019$12,435,000
+18.2%
566,754
+10.2%
0.01%
+14.3%
Q1 2019$10,520,000
+86.1%
514,160
+14.7%
0.01%
+75.0%
Q4 2018$5,652,000
-3.4%
448,174
+17.6%
0.00%0.0%
Q3 2018$5,851,000
+49.2%
381,108
+27.4%
0.00%
+33.3%
Q2 2018$3,921,000
+57.0%
299,042
-2.3%
0.00%
+50.0%
Q1 2018$2,497,000
-5.1%
305,995
+3.0%
0.00%0.0%
Q4 2017$2,632,000
+12.0%
297,046
+40.8%
0.00%0.0%
Q3 2017$2,349,000
+31.3%
211,040
+5.7%
0.00%0.0%
Q2 2017$1,789,000
+14.2%
199,654
+0.6%
0.00%0.0%
Q1 2017$1,566,000
-2.5%
198,419
+5.9%
0.00%0.0%
Q4 2016$1,606,000
+10.2%
187,304
+5.6%
0.00%0.0%
Q3 2016$1,458,000
+101.7%
177,294
+97.2%
0.00%
+100.0%
Q2 2016$723,000
+19.3%
89,8880.0%0.00%0.0%
Q1 2016$606,000
-14.4%
89,8880.0%0.00%0.0%
Q4 2015$708,000
+37.2%
89,8880.0%0.00%0.0%
Q3 2015$516,000
+37.2%
89,888
+29.4%
0.00%0.0%
Q2 2015$376,000
+130.7%
69,488
+48.2%
0.00%
Q1 2014$163,000
-4.1%
46,9000.0%0.00%
Q4 2013$170,000
+18.9%
46,9000.0%0.00%
Q3 2013$143,000
-23.5%
46,9000.0%0.00%
Q2 2013$187,00046,9000.00%
Other shareholders
NEOGENOMICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 396,327$8,109,0006.56%
Cowen Prime Services LLC 584,766$11,964,0006.20%
1492 Capital Management LLC 269,488$5,514,0004.67%
First Light Asset Management, LLC 1,604,611$32,830,0004.27%
PERKINS CAPITAL MANAGEMENT INC 264,650$5,415,0003.56%
FALCON POINT CAPITAL, LLC 219,992$4,501,0002.45%
Granite Investment Partners, LLC 1,764,090$36,093,0002.05%
Ranger Investment Management 1,209,535$24,747,0001.79%
EMERALD ADVISERS, LLC 1,878,901$38,442,0001.56%
EMERALD MUTUAL FUND ADVISERS TRUST 1,875,759$38,378,0001.54%
View complete list of NEOGENOMICS INC shareholders